{"transactions":[{"id":679792,"issuer":{"id":5345,"kind":"organization","name":"Cytek Biosciences, Inc."},"owners":[{"id":21194,"kind":"person","name":"Chin Richard","position":1,"cik":"0001337252","reported_name":"Chin Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-08-20T20:27:05.000Z","date":"2026-08-18","kind":"exercise","planned":false,"acquired":false,"shares":6107,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (the \"RSU Award\") represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying the RSU Award shall vest over 3 years, with 2/36 of the total shares underlying the RSU Award vesting on August 18, 2025; 3/36 of the total shares underlying the RSU Award vesting on November 18, 2025 and each November 18 thereafter; 3/36 of the total shares underlying the RSU Award vesting on March 10, 2026 and each March 10 thereafter; 3/36 of the total shares underlying the RSU Award vesting on May 18, 2026 and each May 18 thereafter; and 3/36 of the total shares underlying the RSU Award vesting on August 18, 2026 and each August 18 thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The shares underlying the RSU Award shall vest over 3 years, with 2/36 of the total shares underlying the RSU Award vesting on August 18, 2025; 3/36 of the total shares underlying the RSU Award vesting on November 18, 2025 and each November 18 thereafter; 3/36 of the total shares underlying the RSU Award vesting on March 10, 2026 and each March 10 thereafter; 3/36 of the total shares underlying the RSU Award vesting on May 18, 2026 and each May 18 thereafter; and 3/36 of the total shares underlying the RSU Award vesting on August 18, 2026 and each August 18 thereafter."}],"balance_after":44790,"derivative":{"underlying":"Common Stock","underlying_shares":6107},"source":{"system":"sec-edgar","filing":"0001337252-26-000005","document":"form4-08202026_080801.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1337252/000133725226000005/form4-08202026_080801.xml","form_type":"4"}},{"id":679791,"issuer":{"id":5345,"kind":"organization","name":"Cytek Biosciences, Inc."},"owners":[{"id":21194,"kind":"person","name":"Chin Richard","position":1,"cik":"0001337252","reported_name":"Chin Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-08-20T20:27:05.000Z","date":"2026-08-18","kind":"exercise","planned":false,"acquired":true,"shares":6107,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit (the \"RSU Award\") represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":28499,"source":{"system":"sec-edgar","filing":"0001337252-26-000005","document":"form4-08202026_080801.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1337252/000133725226000005/form4-08202026_080801.xml","form_type":"4"}},{"id":739401,"issuer":{"id":5345,"kind":"organization","name":"Cytek Biosciences, Inc."},"owners":[{"id":21194,"kind":"person","name":"Chin Richard","position":1,"cik":"0001337252","reported_name":"Chin Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2026-06-12T23:27:56.000Z","date":"2026-06-10","kind":"grant","planned":false,"acquired":true,"shares":18261,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"100% of the shares subject to the option shall vest on the earlier of June 10, 2027 and the date of the Issuer's 2027 annual meeting of stockholders  (provided such meeting is held in June 2027)."}],"balance_after":18261,"derivative":{"exercise_price":4.05,"expiration_date":"2036-06-10","underlying":"Common Stock","underlying_shares":18261},"source":{"system":"sec-edgar","filing":"0001337252-26-000003","document":"form4-06122026_110652.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1337252/000133725226000003/form4-06122026_110652.xml","form_type":"4"}},{"id":739400,"issuer":{"id":5345,"kind":"organization","name":"Cytek Biosciences, Inc."},"owners":[{"id":21194,"kind":"person","name":"Chin Richard","position":1,"cik":"0001337252","reported_name":"Chin Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-06-12T23:27:56.000Z","date":"2026-06-10","kind":"grant","planned":false,"acquired":true,"shares":33333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (the \"RSU Award\") represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"100% of the shares subject to the RSU Award shall vest on the earlier of June 10, 2027 and the date of the Issuer's 2027 annual meeting of stockholders (provided such meeting is held in June 2027)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"100% of the shares subject to the RSU Award shall vest on the earlier of June 10, 2027 and the date of the Issuer's 2027 annual meeting of stockholders (provided such meeting is held in June 2027)."}],"balance_after":33333,"derivative":{"underlying":"Common Stock","underlying_shares":33333},"source":{"system":"sec-edgar","filing":"0001337252-26-000003","document":"form4-06122026_110652.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1337252/000133725226000003/form4-06122026_110652.xml","form_type":"4"}},{"id":769693,"issuer":{"id":5345,"kind":"organization","name":"Cytek Biosciences, Inc."},"owners":[{"id":21194,"kind":"person","name":"Chin Richard","position":1,"cik":"0001337252","reported_name":"Chin Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-05-20T21:59:27.000Z","date":"2026-05-18","kind":"exercise","planned":false,"acquired":false,"shares":6107,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (the \"RSU Award\") represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"2/36 of the total shares subject to the RSU Award shall vest on August 18, 2025; 3/36 of the total shares subject to the RSU Award shall vest on November 18, 2025 and each November 18 thereafter; 3/36 of the total shares underlying the RSU Award shall vest on March 10, 2026 and each March 10 thereafter; 3/36 of the total shares underlying the RSU Award vesting shall vest on May 18, 2026 and each May 18 thereafter; and 3/36 of the total shares underlying the RSU Award shall vest on August 18, 2026 and each August 18 thereafter, until fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"2/36 of the total shares subject to the RSU Award shall vest on August 18, 2025; 3/36 of the total shares subject to the RSU Award shall vest on November 18, 2025 and each November 18 thereafter; 3/36 of the total shares underlying the RSU Award shall vest on March 10, 2026 and each March 10 thereafter; 3/36 of the total shares underlying the RSU Award vesting shall vest on May 18, 2026 and each May 18 thereafter; and 3/36 of the total shares underlying the RSU Award shall vest on August 18, 2026 and each August 18 thereafter, until fully vested."}],"balance_after":50897,"derivative":{"underlying":"Common Stock","underlying_shares":6107},"source":{"system":"sec-edgar","filing":"0001337252-26-000002","document":"form4-05202026_090523.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1337252/000133725226000002/form4-05202026_090523.xml","form_type":"4"}},{"id":769692,"issuer":{"id":5345,"kind":"organization","name":"Cytek Biosciences, Inc."},"owners":[{"id":21194,"kind":"person","name":"Chin Richard","position":1,"cik":"0001337252","reported_name":"Chin Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-20T21:59:27.000Z","date":"2026-05-18","kind":"exercise","planned":false,"acquired":true,"shares":6107,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit (the \"RSU Award\") represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":22392,"source":{"system":"sec-edgar","filing":"0001337252-26-000002","document":"form4-05202026_090523.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1337252/000133725226000002/form4-05202026_090523.xml","form_type":"4"}},{"id":845727,"issuer":{"id":5345,"kind":"organization","name":"Cytek Biosciences, Inc."},"owners":[{"id":21194,"kind":"person","name":"Chin Richard","position":1,"cik":"0001337252","reported_name":"Chin Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-03-12T20:41:17.000Z","date":"2026-03-10","kind":"exercise","planned":false,"acquired":false,"shares":6107,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (the \"RSU Award\") represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"2/36 of the total shares subject to the RSU Award shall vest on August 18, 2025; 3/36 of the total shares subject to the RSU Award shall vest on November 18, 2025 and each November 18 thereafter; 3/36 of the total shares underlying the RSU Award shall vest on March 10, 2026 and each March 10 thereafter; 3/36 of the total shares underlying the RSU Award vesting shall vest on May 18, 2026 and each May 18 thereafter; and 3/36 of the total shares underlying the RSU Award shall vest on August 18, 2026 and each August 18 thereafter, until fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"2/36 of the total shares subject to the RSU Award shall vest on August 18, 2025; 3/36 of the total shares subject to the RSU Award shall vest on November 18, 2025 and each November 18 thereafter; 3/36 of the total shares underlying the RSU Award shall vest on March 10, 2026 and each March 10 thereafter; 3/36 of the total shares underlying the RSU Award vesting shall vest on May 18, 2026 and each May 18 thereafter; and 3/36 of the total shares underlying the RSU Award shall vest on August 18, 2026 and each August 18 thereafter, until fully vested."}],"balance_after":57004,"derivative":{"underlying":"Common Stock","underlying_shares":6107},"source":{"system":"sec-edgar","filing":"0001337252-26-000001","document":"form4-03122026_080314.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1337252/000133725226000001/form4-03122026_080314.xml","form_type":"4"}},{"id":845726,"issuer":{"id":5345,"kind":"organization","name":"Cytek Biosciences, Inc."},"owners":[{"id":21194,"kind":"person","name":"Chin Richard","position":1,"cik":"0001337252","reported_name":"Chin Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-03-12T20:41:17.000Z","date":"2026-03-10","kind":"exercise","planned":false,"acquired":true,"shares":6107,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit (the \"RSU Award\") represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":16285,"source":{"system":"sec-edgar","filing":"0001337252-26-000001","document":"form4-03122026_080314.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1337252/000133725226000001/form4-03122026_080314.xml","form_type":"4"}},{"id":992349,"issuer":{"id":5345,"kind":"organization","name":"Cytek Biosciences, Inc."},"owners":[{"id":21194,"kind":"person","name":"Chin Richard","position":1,"cik":"0001337252","reported_name":"Chin Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-11-20T23:50:28.000Z","date":"2025-11-18","kind":"exercise","planned":false,"acquired":false,"shares":6107,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (the \"RSU Award\") represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"2/36 of the total shares subject to the RSU Award shall vest on August 18, 2025; 3/36 of the total shares subject to the RSU Award shall vest on November 18, 2025 and each November 18 thereafter; 3/36 of the total shares underlying the RSU Award shall vest on March 10, 2026 and each March 10 thereafter; 3/36 of the total shares underlying the RSU Award vesting shall vest on May 18, 2026 and each May 18 thereafter; and 3/36 of the total shares underlying the RSU Award shall vest on August 18, 2026 and each August 18 thereafter, until fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"2/36 of the total shares subject to the RSU Award shall vest on August 18, 2025; 3/36 of the total shares subject to the RSU Award shall vest on November 18, 2025 and each November 18 thereafter; 3/36 of the total shares underlying the RSU Award shall vest on March 10, 2026 and each March 10 thereafter; 3/36 of the total shares underlying the RSU Award vesting shall vest on May 18, 2026 and each May 18 thereafter; and 3/36 of the total shares underlying the RSU Award shall vest on August 18, 2026 and each August 18 thereafter, until fully vested."}],"balance_after":63111,"derivative":{"underlying":"Common Stock","underlying_shares":6107},"source":{"system":"sec-edgar","filing":"0001337252-25-000004","document":"form4-11202025_111125.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1337252/000133725225000004/form4-11202025_111125.xml","form_type":"4"}},{"id":992348,"issuer":{"id":5345,"kind":"organization","name":"Cytek Biosciences, Inc."},"owners":[{"id":21194,"kind":"person","name":"Chin Richard","position":1,"cik":"0001337252","reported_name":"Chin Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-20T23:50:28.000Z","date":"2025-11-18","kind":"exercise","planned":false,"acquired":true,"shares":6107,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit (the \"RSU Award\") represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":10178,"source":{"system":"sec-edgar","filing":"0001337252-25-000004","document":"form4-11202025_111125.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1337252/000133725225000004/form4-11202025_111125.xml","form_type":"4"}},{"id":1060068,"issuer":{"id":5345,"kind":"organization","name":"Cytek Biosciences, Inc."},"owners":[{"id":21194,"kind":"person","name":"Chin Richard","position":1,"cik":"0001337252","reported_name":"Chin Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-08-20T21:41:22.000Z","date":"2025-08-18","kind":"exercise","planned":false,"acquired":false,"shares":4071,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (the \"RSU Award\") represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"2/36 of the total shares subject to the RSU Award shall vest on August 18, 2025; 3/36 of the total shares subject to the RSU Award shall vest on November 18, 2025 and each November 18 thereafter; 3/36 of the total shares underlying the RSU Award shall vest on March 10, 2026 and each March 10 thereafter; 3/36 of the total shares underlying the RSU Award vesting shall vest on May 18, 2026 and each May 18 thereafter; and 3/36 of the total shares underlying the RSU Award shall vest on August 18, 2026 and each August 18 thereafter, until fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"2/36 of the total shares subject to the RSU Award shall vest on August 18, 2025; 3/36 of the total shares subject to the RSU Award shall vest on November 18, 2025 and each November 18 thereafter; 3/36 of the total shares underlying the RSU Award shall vest on March 10, 2026 and each March 10 thereafter; 3/36 of the total shares underlying the RSU Award vesting shall vest on May 18, 2026 and each May 18 thereafter; and 3/36 of the total shares underlying the RSU Award shall vest on August 18, 2026 and each August 18 thereafter, until fully vested."}],"balance_after":69218,"derivative":{"underlying":"Common Stock","underlying_shares":4071},"source":{"system":"sec-edgar","filing":"0001415889-25-022516","document":"form4-08202025_090818.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1337252/000141588925022516/form4-08202025_090818.xml","form_type":"4"}},{"id":1060067,"issuer":{"id":5345,"kind":"organization","name":"Cytek Biosciences, Inc."},"owners":[{"id":21194,"kind":"person","name":"Chin Richard","position":1,"cik":"0001337252","reported_name":"Chin Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-08-20T21:41:22.000Z","date":"2025-08-18","kind":"exercise","planned":false,"acquired":true,"shares":4071,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit (the \"RSU Award\") represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":4071,"source":{"system":"sec-edgar","filing":"0001415889-25-022516","document":"form4-08202025_090818.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1337252/000141588925022516/form4-08202025_090818.xml","form_type":"4"}},{"id":1104750,"issuer":{"id":5345,"kind":"organization","name":"Cytek Biosciences, Inc."},"owners":[{"id":21194,"kind":"person","name":"Chin Richard","position":1,"cik":"0001337252","reported_name":"Chin Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2025-06-20T20:31:59.000Z","date":"2025-06-18","kind":"grant","planned":false,"acquired":true,"shares":39062,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/36 of the total shares subject to the option shall vest monthly over 3 years following the grant date of June 18, 2025."}],"balance_after":39062,"derivative":{"exercise_price":3.07,"expiration_date":"2035-06-17","underlying":"Common Stock","underlying_shares":39062},"source":{"system":"sec-edgar","filing":"0001415889-25-017868","document":"form4-06202025_080655.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1337252/000141588925017868/form4-06202025_080655.xml","form_type":"4"}},{"id":1104749,"issuer":{"id":5345,"kind":"organization","name":"Cytek Biosciences, Inc."},"owners":[{"id":21194,"kind":"person","name":"Chin Richard","position":1,"cik":"0001337252","reported_name":"Chin Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-06-20T20:31:59.000Z","date":"2025-06-18","kind":"grant","planned":false,"acquired":true,"shares":73289,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (the \"RSU Award\") represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"2/36 of the total shares subject to the RSU Award shall vest on August 18, 2025; 3/36 of the total shares subject to the RSU Award shall vest on November 18, 2025 and each November 18 thereafter; 3/36 of the total shares underlying the RSU Award shall vest on March 10, 2026 and each March 10 thereafter; 3/36  of the total shares underlying the RSU Award vesting shall vest on May 18, 2026 and each May 18 thereafter; and 3/36  of the total shares underlying the RSU Award shall vest on August 18, 2026 and each August 18 thereafter, until fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"2/36 of the total shares subject to the RSU Award shall vest on August 18, 2025; 3/36 of the total shares subject to the RSU Award shall vest on November 18, 2025 and each November 18 thereafter; 3/36 of the total shares underlying the RSU Award shall vest on March 10, 2026 and each March 10 thereafter; 3/36  of the total shares underlying the RSU Award vesting shall vest on May 18, 2026 and each May 18 thereafter; and 3/36  of the total shares underlying the RSU Award shall vest on August 18, 2026 and each August 18 thereafter, until fully vested."}],"balance_after":73289,"derivative":{"underlying":"Common Stock","underlying_shares":73289},"source":{"system":"sec-edgar","filing":"0001415889-25-017868","document":"form4-06202025_080655.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1337252/000141588925017868/form4-06202025_080655.xml","form_type":"4"}},{"id":2586454,"issuer":{"id":135544,"kind":"organization","name":"Kindred Biosciences, Inc.","symbol":"KIN"},"owners":[{"id":21194,"kind":"person","name":"Chin Richard","position":1,"cik":"0001337252","reported_name":"Chin Richard","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-08-31T01:46:23.000Z","date":"2021-08-27","kind":"disposition_to_issuer","acquired":false,"shares":394000,"price":4.81,"value":1895140.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F11","text":"This option provided for vesting of 25% of the Option Shares on the annual anniversary of January 20, 2021, with the remaining Option Shares vesting in equal monthly installments over the following three years, subject to continued employment on each such vesting date. Pursuant to the Merger Agreement, the unvested portion of this option was subject to acceleration of vesting. This option was cancelled pursuant to the Merger Agreement in exchange for a cash payment of $1,895,140.00, representing the difference between the per share exercise price of the option and the merger consideration of $9.25 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F11","text":"This option provided for vesting of 25% of the Option Shares on the annual anniversary of January 20, 2021, with the remaining Option Shares vesting in equal monthly installments over the following three years, subject to continued employment on each such vesting date. Pursuant to the Merger Agreement, the unvested portion of this option was subject to acceleration of vesting. This option was cancelled pursuant to the Merger Agreement in exchange for a cash payment of $1,895,140.00, representing the difference between the per share exercise price of the option and the merger consideration of $9.25 per share."}],"balance_after":0,"derivative":{"exercise_price":4.44,"expiration_date":"2031-01-19","underlying":"Common Stock","underlying_shares":394000},"source":{"system":"sec-edgar","filing":"0001250853-21-000092","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1337252/000125085321000092/primary_doc.xml","form_type":"4"}},{"id":2586453,"issuer":{"id":135544,"kind":"organization","name":"Kindred Biosciences, Inc.","symbol":"KIN"},"owners":[{"id":21194,"kind":"person","name":"Chin Richard","position":1,"cik":"0001337252","reported_name":"Chin Richard","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-08-31T01:46:23.000Z","date":"2021-08-27","kind":"disposition_to_issuer","acquired":false,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F10","text":"This option vested 25% of the Option Shares on the annual anniversary of January 17, 2020, with the remaining Option Shares vesting in equal monthly installments over the following three years, subject to continued employment on each such vesting date. Pursuant to the Merger Agreement, the unvested portion of this option was subject to acceleration of vesting. This option was cancelled pursuant to the Merger Agreement in exchange for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"This option vested 25% of the Option Shares on the annual anniversary of January 17, 2020, with the remaining Option Shares vesting in equal monthly installments over the following three years, subject to continued employment on each such vesting date. Pursuant to the Merger Agreement, the unvested portion of this option was subject to acceleration of vesting. This option was cancelled pursuant to the Merger Agreement in exchange for no consideration."}],"balance_after":0,"derivative":{"exercise_price":9.84,"expiration_date":"2030-01-16","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001250853-21-000092","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1337252/000125085321000092/primary_doc.xml","form_type":"4"}},{"id":2586452,"issuer":{"id":135544,"kind":"organization","name":"Kindred Biosciences, Inc.","symbol":"KIN"},"owners":[{"id":21194,"kind":"person","name":"Chin Richard","position":1,"cik":"0001337252","reported_name":"Chin Richard","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-08-31T01:46:23.000Z","date":"2021-08-27","kind":"disposition_to_issuer","acquired":false,"shares":400000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F9","text":"This option vested 25% of the Option Shares on the annual anniversary of February 1, 2019, with the remaining Option Shares vesting in equal monthly installments over the following three years, subject to continued employment on each such vesting date. Pursuant to the Merger Agreement, the unvested portion of this option was subject to acceleration of vesting. This option was cancelled pursuant to the Merger Agreement in exchange for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"This option vested 25% of the Option Shares on the annual anniversary of February 1, 2019, with the remaining Option Shares vesting in equal monthly installments over the following three years, subject to continued employment on each such vesting date. Pursuant to the Merger Agreement, the unvested portion of this option was subject to acceleration of vesting. This option was cancelled pursuant to the Merger Agreement in exchange for no consideration."}],"balance_after":0,"derivative":{"exercise_price":9.91,"expiration_date":"2029-01-31","underlying":"Common Stock","underlying_shares":400000},"source":{"system":"sec-edgar","filing":"0001250853-21-000092","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1337252/000125085321000092/primary_doc.xml","form_type":"4"}},{"id":2586451,"issuer":{"id":135544,"kind":"organization","name":"Kindred Biosciences, Inc.","symbol":"KIN"},"owners":[{"id":21194,"kind":"person","name":"Chin Richard","position":1,"cik":"0001337252","reported_name":"Chin Richard","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-08-31T01:46:23.000Z","date":"2021-08-27","kind":"disposition_to_issuer","acquired":false,"shares":175000,"price":0.5,"value":87500.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F8","text":"This option vested 25% of the Option Shares on the annual anniversary of January 22, 2018, with the remaining Option Shares vesting in equal monthly installments over the following three years, subject to continued employment on each such vesting date. Pursuant to the Merger Agreement, the unvested portion of this option was subject to acceleration of vesting. This option was cancelled pursuant to the Merger Agreement in exchange for a cash payment of $87,500.00, representing the difference between the per share exercise price of the option and the merger consideration of $9.25 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"This option vested 25% of the Option Shares on the annual anniversary of January 22, 2018, with the remaining Option Shares vesting in equal monthly installments over the following three years, subject to continued employment on each such vesting date. Pursuant to the Merger Agreement, the unvested portion of this option was subject to acceleration of vesting. This option was cancelled pursuant to the Merger Agreement in exchange for a cash payment of $87,500.00, representing the difference between the per share exercise price of the option and the merger consideration of $9.25 per share."}],"balance_after":0,"derivative":{"exercise_price":8.75,"expiration_date":"2028-01-22","underlying":"Common Stock","underlying_shares":175000},"source":{"system":"sec-edgar","filing":"0001250853-21-000092","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1337252/000125085321000092/primary_doc.xml","form_type":"4"}},{"id":2586450,"issuer":{"id":135544,"kind":"organization","name":"Kindred Biosciences, Inc.","symbol":"KIN"},"owners":[{"id":21194,"kind":"person","name":"Chin Richard","position":1,"cik":"0001337252","reported_name":"Chin Richard","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-08-31T01:46:23.000Z","date":"2021-08-27","kind":"disposition_to_issuer","acquired":false,"shares":175000,"price":2.85,"value":498750.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"This option, which vested 25% of the Option Shares on the annual anniversary of January 23, 2017, with the remaining Option Shares vested in equal monthly installments over the following three years, subject to continued employment on each such vesting date, was cancelled pursuant to the Merger Agreement in exchange for a cash payment of $498,750.00, representing the difference between the per share exercise price of the option and the merger consideration of $9.25 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"This option, which vested 25% of the Option Shares on the annual anniversary of January 23, 2017, with the remaining Option Shares vested in equal monthly installments over the following three years, subject to continued employment on each such vesting date, was cancelled pursuant to the Merger Agreement in exchange for a cash payment of $498,750.00, representing the difference between the per share exercise price of the option and the merger consideration of $9.25 per share."}],"balance_after":0,"derivative":{"exercise_price":6.4,"expiration_date":"2027-01-23","underlying":"Common Stock","underlying_shares":175000},"source":{"system":"sec-edgar","filing":"0001250853-21-000092","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1337252/000125085321000092/primary_doc.xml","form_type":"4"}},{"id":2586449,"issuer":{"id":135544,"kind":"organization","name":"Kindred Biosciences, Inc.","symbol":"KIN"},"owners":[{"id":21194,"kind":"person","name":"Chin Richard","position":1,"cik":"0001337252","reported_name":"Chin Richard","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-08-31T01:46:23.000Z","date":"2021-08-27","kind":"disposition_to_issuer","acquired":false,"shares":197771,"price":5.8,"value":1147071.8,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"This option, which vested 25% of the Option Shares on the annual anniversary of January 8, 2016, with the remaining Option Shares vested in equal monthly installments over the following three years, subject to continued employment on each such vesting date, was cancelled pursuant to the Merger Agreement in exchange for a cash payment of $1,147,071.80, representing the difference between the per share exercise price of the option and the merger consideration of $9.25 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"This option, which vested 25% of the Option Shares on the annual anniversary of January 8, 2016, with the remaining Option Shares vested in equal monthly installments over the following three years, subject to continued employment on each such vesting date, was cancelled pursuant to the Merger Agreement in exchange for a cash payment of $1,147,071.80, representing the difference between the per share exercise price of the option and the merger consideration of $9.25 per share."}],"balance_after":0,"derivative":{"exercise_price":3.45,"expiration_date":"2026-01-08","underlying":"Common Stock","underlying_shares":197771},"source":{"system":"sec-edgar","filing":"0001250853-21-000092","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1337252/000125085321000092/primary_doc.xml","form_type":"4"}},{"id":2586448,"issuer":{"id":135544,"kind":"organization","name":"Kindred Biosciences, Inc.","symbol":"KIN"},"owners":[{"id":21194,"kind":"person","name":"Chin Richard","position":1,"cik":"0001337252","reported_name":"Chin Richard","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-08-31T01:46:23.000Z","date":"2021-08-27","kind":"disposition_to_issuer","acquired":false,"shares":197771,"price":2.79,"value":551781.09,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This option, which vested 25% of the Option Shares on the annual anniversary of February 5, 2015, with the remaining Option Shares vested in equal monthly installments over the following three years, subject to continued employment on each such vesting date, was cancelled pursuant to the Merger Agreement in exchange for a cash payment of $551,781.09, representing the difference between the per share exercise price of the option and the merger consideration of $9.25 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This option, which vested 25% of the Option Shares on the annual anniversary of February 5, 2015, with the remaining Option Shares vested in equal monthly installments over the following three years, subject to continued employment on each such vesting date, was cancelled pursuant to the Merger Agreement in exchange for a cash payment of $551,781.09, representing the difference between the per share exercise price of the option and the merger consideration of $9.25 per share."}],"balance_after":0,"derivative":{"exercise_price":6.46,"expiration_date":"2025-02-05","underlying":"Common Stock","underlying_shares":197771},"source":{"system":"sec-edgar","filing":"0001250853-21-000092","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1337252/000125085321000092/primary_doc.xml","form_type":"4"}},{"id":2586447,"issuer":{"id":135544,"kind":"organization","name":"Kindred Biosciences, Inc.","symbol":"KIN"},"owners":[{"id":21194,"kind":"person","name":"Chin Richard","position":1,"cik":"0001337252","reported_name":"Chin Richard","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-08-31T01:46:23.000Z","date":"2021-08-27","kind":"disposition_to_issuer","acquired":false,"shares":350000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This option, which vested 25% of the Option Shares on the annual anniversary of February 4, 2014, with the remaining Option Shares vested in equal monthly installments over the following three years, subject to continued employment on each such vesting date, was cancelled pursuant to the Merger Agreement in exchange for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option, which vested 25% of the Option Shares on the annual anniversary of February 4, 2014, with the remaining Option Shares vested in equal monthly installments over the following three years, subject to continued employment on each such vesting date, was cancelled pursuant to the Merger Agreement in exchange for no consideration."}],"balance_after":0,"derivative":{"exercise_price":16.52,"expiration_date":"2024-02-04","underlying":"Common Stock","underlying_shares":350000},"source":{"system":"sec-edgar","filing":"0001250853-21-000092","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1337252/000125085321000092/primary_doc.xml","form_type":"4"}},{"id":2586446,"issuer":{"id":135544,"kind":"organization","name":"Kindred Biosciences, Inc.","symbol":"KIN"},"owners":[{"id":21194,"kind":"person","name":"Chin Richard","position":1,"cik":"0001337252","reported_name":"Chin Richard","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-08-31T01:46:23.000Z","date":"2021-08-27","kind":"disposition_to_issuer","acquired":false,"shares":400000,"price":8.89,"value":3556000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This option, which vested 25% of the total number of shares underlying the option (\"Option Shares\") on the annual anniversary of February 4, 2013, with the remaining Option Shares vested in equal monthly installments over the following three years, subject to continued employment on each such vesting date, was cancelled pursuant to the Merger Agreement in exchange for a cash payment of $3,556,000, representing the difference between the per share exercise price of the option and the merger consideration of $9.25 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option, which vested 25% of the total number of shares underlying the option (\"Option Shares\") on the annual anniversary of February 4, 2013, with the remaining Option Shares vested in equal monthly installments over the following three years, subject to continued employment on each such vesting date, was cancelled pursuant to the Merger Agreement in exchange for a cash payment of $3,556,000, representing the difference between the per share exercise price of the option and the merger consideration of $9.25 per share."}],"balance_after":0,"derivative":{"exercise_price":0.36,"expiration_date":"2023-02-04","underlying":"Common Stock","underlying_shares":400000},"source":{"system":"sec-edgar","filing":"0001250853-21-000092","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1337252/000125085321000092/primary_doc.xml","form_type":"4"}},{"id":2586445,"issuer":{"id":135544,"kind":"organization","name":"Kindred Biosciences, Inc.","symbol":"KIN"},"owners":[{"id":21194,"kind":"person","name":"Chin Richard","position":1,"cik":"0001337252","reported_name":"Chin Richard","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-08-31T01:46:23.000Z","date":"2021-08-27","kind":"disposition_to_issuer","acquired":false,"shares":2000,"price":9.25,"value":18500.0,"ownership":{"direct":false,"nature":"By reporting person as custodian for daughter"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Disposed of pursuant to the Merger Agreement in exchange for cash payment of $9.25 per share."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001250853-21-000092","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1337252/000125085321000092/primary_doc.xml","form_type":"4"}},{"id":2586444,"issuer":{"id":135544,"kind":"organization","name":"Kindred Biosciences, Inc.","symbol":"KIN"},"owners":[{"id":21194,"kind":"person","name":"Chin Richard","position":1,"cik":"0001337252","reported_name":"Chin Richard","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-08-31T01:46:23.000Z","date":"2021-08-27","kind":"disposition_to_issuer","acquired":false,"shares":2000,"price":9.25,"value":18500.0,"ownership":{"direct":false,"nature":"By reporting person as custodian for son"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Disposed of pursuant to the Merger Agreement in exchange for cash payment of $9.25 per share."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001250853-21-000092","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1337252/000125085321000092/primary_doc.xml","form_type":"4"}},{"id":2586443,"issuer":{"id":135544,"kind":"organization","name":"Kindred Biosciences, Inc.","symbol":"KIN"},"owners":[{"id":21194,"kind":"person","name":"Chin Richard","position":1,"cik":"0001337252","reported_name":"Chin Richard","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-08-31T01:46:23.000Z","date":"2021-08-27","kind":"disposition_to_issuer","acquired":false,"shares":2000,"price":9.25,"value":18500.0,"ownership":{"direct":false,"nature":"By reporting person as custodian for daughter"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Disposed of pursuant to the Merger Agreement in exchange for cash payment of $9.25 per share."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001250853-21-000092","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1337252/000125085321000092/primary_doc.xml","form_type":"4"}},{"id":2586442,"issuer":{"id":135544,"kind":"organization","name":"Kindred Biosciences, Inc.","symbol":"KIN"},"owners":[{"id":21194,"kind":"person","name":"Chin Richard","position":1,"cik":"0001337252","reported_name":"Chin Richard","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-08-31T01:46:23.000Z","date":"2021-08-27","kind":"disposition_to_issuer","acquired":false,"shares":2000,"price":9.25,"value":18500.0,"ownership":{"direct":false,"nature":"By reporting person as custodian for son"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Disposed of pursuant to the Merger Agreement in exchange for cash payment of $9.25 per share."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001250853-21-000092","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1337252/000125085321000092/primary_doc.xml","form_type":"4"}},{"id":2586441,"issuer":{"id":135544,"kind":"organization","name":"Kindred Biosciences, Inc.","symbol":"KIN"},"owners":[{"id":21194,"kind":"person","name":"Chin Richard","position":1,"cik":"0001337252","reported_name":"Chin Richard","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-08-31T01:46:23.000Z","date":"2021-08-27","kind":"disposition_to_issuer","acquired":false,"shares":1709271,"price":9.25,"value":15810756.75,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents 1,709,271 shares of common stock that were disposed of at the effective time of the merger (the \"Merger\") contemplated by the agreement and plan of merger, dated as of June 15, 2021, by and among the Elanco Animal Health Incorporated, Knight Merger Sub, Inc., and Kindred Biosciences, Inc. (the \"Merger Agreement\") in exchange for a cash payment of $9.25 per share. Certain of these securities were restricted stock units (\"RSUs\") that represented the reporting person's right to receive the Kindred Biosciences, Inc.'s common stock. Pursuant to the Merger Agreement, the RSUs were subject to acceleration of vesting, cancelled and converted automatically into the right to receive a cash payment of $9.25 per share, subject to any required withholding of taxes."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001250853-21-000092","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1337252/000125085321000092/primary_doc.xml","form_type":"4"}},{"id":2614476,"issuer":{"id":135544,"kind":"organization","name":"Kindred Biosciences, Inc.","symbol":"KIN"},"owners":[{"id":21194,"kind":"person","name":"Chin Richard","position":1,"cik":"0001337252","reported_name":"Chin Richard","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-08-04T19:00:33.000Z","date":"2021-08-02","kind":"sale","acquired":false,"shares":40000,"price":9.206,"value":368240.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 22, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.20 to $9.215, inclusive. The reporting person undertakes to provide to Kindred Biosciences, Inc., any security holder of Kindred Biosciences, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2) to this Form 4."}],"balance_after":1534271,"source":{"system":"sec-edgar","filing":"0001250853-21-000081","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1337252/000125085321000081/primary_doc.xml","form_type":"4"}},{"id":2614475,"issuer":{"id":135544,"kind":"organization","name":"Kindred Biosciences, Inc.","symbol":"KIN"},"owners":[{"id":21194,"kind":"person","name":"Chin Richard","position":1,"cik":"0001337252","reported_name":"Chin Richard","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-08-04T19:00:33.000Z","date":"2021-07-22","kind":"gift","acquired":false,"shares":320000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":1574271,"source":{"system":"sec-edgar","filing":"0001250853-21-000081","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1337252/000125085321000081/primary_doc.xml","form_type":"4"}},{"id":2639161,"issuer":{"id":135544,"kind":"organization","name":"Kindred Biosciences, Inc.","symbol":"KIN"},"owners":[{"id":21194,"kind":"person","name":"Chin Richard","position":1,"cik":"0001337252","reported_name":"Chin Richard","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-07-07T16:02:42.000Z","date":"2021-07-02","kind":"sale","acquired":false,"shares":40000,"price":9.177,"value":367080.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 22, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.17 to $9.19, inclusive. The reporting person undertakes to provide to Kindred Biosciences, Inc., any security holder of Kindred Biosciences, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2) to this Form 4."}],"balance_after":1894271,"source":{"system":"sec-edgar","filing":"0001250853-21-000071","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1337252/000125085321000071/primary_doc.xml","form_type":"4"}},{"id":2663149,"issuer":{"id":135544,"kind":"organization","name":"Kindred Biosciences, Inc.","symbol":"KIN"},"owners":[{"id":21194,"kind":"person","name":"Chin Richard","position":1,"cik":"0001337252","reported_name":"Chin Richard","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-06-18T01:30:55.000Z","date":"2021-06-16","kind":"sale","acquired":false,"shares":40000,"price":9.1817,"value":367268.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 22, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.165 to $9.19, inclusive. The reporting person undertakes to provide to Kindred Biosciences, Inc., any security holder of Kindred Biosciences, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2) to this Form 4."}],"balance_after":1934271,"source":{"system":"sec-edgar","filing":"0001250853-21-000066","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1337252/000125085321000066/primary_doc.xml","form_type":"4"}},{"id":2881038,"issuer":{"id":135544,"kind":"organization","name":"Kindred Biosciences, Inc.","symbol":"KIN"},"owners":[{"id":21194,"kind":"person","name":"Chin Richard","position":1,"cik":"0001337252","reported_name":"Chin Richard","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2021-02-03T20:20:36.000Z","date":"2021-02-01","kind":"exercise","acquired":false,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"In February 2019, the reporting person was granted 50,000 restricted stock units that vest in four equal annual installments."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"In February 2019, the reporting person was granted 50,000 restricted stock units that vest in four equal annual installments."}],"balance_after":25000,"derivative":{"underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001250853-21-000024","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1337252/000125085321000024/primary_doc.xml","form_type":"4"}},{"id":2881037,"issuer":{"id":135544,"kind":"organization","name":"Kindred Biosciences, Inc.","symbol":"KIN"},"owners":[{"id":21194,"kind":"person","name":"Chin Richard","position":1,"cik":"0001337252","reported_name":"Chin Richard","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-02-03T20:20:36.000Z","date":"2021-02-01","kind":"tax_withholding","acquired":false,"shares":6582,"price":5,"value":32910.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"These shares are being surrendered to satisfy a tax withholding obligation of the reporting person."}],"balance_after":1974271,"source":{"system":"sec-edgar","filing":"0001250853-21-000024","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1337252/000125085321000024/primary_doc.xml","form_type":"4"}},{"id":2881036,"issuer":{"id":135544,"kind":"organization","name":"Kindred Biosciences, Inc.","symbol":"KIN"},"owners":[{"id":21194,"kind":"person","name":"Chin Richard","position":1,"cik":"0001337252","reported_name":"Chin Richard","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-02-03T20:20:36.000Z","date":"2021-02-01","kind":"exercise","acquired":true,"shares":12500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":1980853,"source":{"system":"sec-edgar","filing":"0001250853-21-000024","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1337252/000125085321000024/primary_doc.xml","form_type":"4"}},{"id":2894913,"issuer":{"id":135544,"kind":"organization","name":"Kindred Biosciences, Inc.","symbol":"KIN"},"owners":[{"id":21194,"kind":"person","name":"Chin Richard","position":1,"cik":"0001337252","reported_name":"Chin Richard","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2021-01-27T01:36:25.000Z","date":"2021-01-22","kind":"exercise","acquired":false,"shares":37500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On January 22, 2018, the reporting person was granted 150,000 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On January 22, 2018, the reporting person was granted 150,000 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":37500,"derivative":{"underlying":"Common Stock","underlying_shares":37500},"source":{"system":"sec-edgar","filing":"0001250853-21-000021","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1337252/000125085321000021/primary_doc.xml","form_type":"4"}},{"id":2894912,"issuer":{"id":135544,"kind":"organization","name":"Kindred Biosciences, Inc.","symbol":"KIN"},"owners":[{"id":21194,"kind":"person","name":"Chin Richard","position":1,"cik":"0001337252","reported_name":"Chin Richard","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-01-27T01:36:25.000Z","date":"2021-01-23","kind":"tax_withholding","acquired":false,"shares":13163,"price":4.93,"value":64893.59,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"These shares are being surrendered to satisfy a tax withholding obligation of the reporting person."}],"balance_after":1968353,"source":{"system":"sec-edgar","filing":"0001250853-21-000021","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1337252/000125085321000021/primary_doc.xml","form_type":"4"}},{"id":2894911,"issuer":{"id":135544,"kind":"organization","name":"Kindred Biosciences, Inc.","symbol":"KIN"},"owners":[{"id":21194,"kind":"person","name":"Chin Richard","position":1,"cik":"0001337252","reported_name":"Chin Richard","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-01-27T01:36:25.000Z","date":"2021-01-22","kind":"tax_withholding","acquired":false,"shares":19744,"price":4.93,"value":97337.92,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"These shares are being surrendered to satisfy a tax withholding obligation of the reporting person."}],"balance_after":1981516,"source":{"system":"sec-edgar","filing":"0001250853-21-000021","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1337252/000125085321000021/primary_doc.xml","form_type":"4"}},{"id":2894910,"issuer":{"id":135544,"kind":"organization","name":"Kindred Biosciences, Inc.","symbol":"KIN"},"owners":[{"id":21194,"kind":"person","name":"Chin Richard","position":1,"cik":"0001337252","reported_name":"Chin Richard","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-01-27T01:36:25.000Z","date":"2021-01-22","kind":"exercise","acquired":true,"shares":37500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":2001260,"source":{"system":"sec-edgar","filing":"0001250853-21-000021","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1337252/000125085321000021/primary_doc.xml","form_type":"4"}},{"id":2901821,"issuer":{"id":135544,"kind":"organization","name":"Kindred Biosciences, Inc.","symbol":"KIN"},"owners":[{"id":21194,"kind":"person","name":"Chin Richard","position":1,"cik":"0001337252","reported_name":"Chin Richard","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-01-21T00:20:47.000Z","date":"2021-01-20","kind":"grant","acquired":true,"shares":394000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option will vest as to 25% after one year following the date of grant, and the remainder will vest in 36 equal monthly installments over the following three years."}],"balance_after":394000,"derivative":{"exercise_price":4.44,"expiration_date":"2031-01-19","underlying":"Common Stock","underlying_shares":394000},"source":{"system":"sec-edgar","filing":"0001250853-21-000014","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1337252/000125085321000014/primary_doc.xml","form_type":"4"}},{"id":2901820,"issuer":{"id":135544,"kind":"organization","name":"Kindred Biosciences, Inc.","symbol":"KIN"},"owners":[{"id":21194,"kind":"person","name":"Chin Richard","position":1,"cik":"0001337252","reported_name":"Chin Richard","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2021-01-21T00:20:47.000Z","date":"2021-01-17","kind":"exercise","acquired":false,"shares":37500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On January 17, 2020, the reporting person was granted 150,000 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On January 17, 2020, the reporting person was granted 150,000 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":112500,"derivative":{"underlying":"Common Stock","underlying_shares":37500},"source":{"system":"sec-edgar","filing":"0001250853-21-000014","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1337252/000125085321000014/primary_doc.xml","form_type":"4"}},{"id":2901819,"issuer":{"id":135544,"kind":"organization","name":"Kindred Biosciences, Inc.","symbol":"KIN"},"owners":[{"id":21194,"kind":"person","name":"Chin Richard","position":1,"cik":"0001337252","reported_name":"Chin Richard","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-01-21T00:20:47.000Z","date":"2021-01-17","kind":"tax_withholding","acquired":false,"shares":21128,"price":4.95,"value":104583.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"These shares are being surrendered to satisfy a tax withholding obligation of the reporting person."}],"balance_after":1963760,"source":{"system":"sec-edgar","filing":"0001250853-21-000014","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1337252/000125085321000014/primary_doc.xml","form_type":"4"}},{"id":2901818,"issuer":{"id":135544,"kind":"organization","name":"Kindred Biosciences, Inc.","symbol":"KIN"},"owners":[{"id":21194,"kind":"person","name":"Chin Richard","position":1,"cik":"0001337252","reported_name":"Chin Richard","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-01-21T00:20:47.000Z","date":"2021-01-17","kind":"exercise","acquired":true,"shares":37500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":1984888,"source":{"system":"sec-edgar","filing":"0001250853-21-000014","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1337252/000125085321000014/primary_doc.xml","form_type":"4"}},{"id":3273521,"issuer":{"id":135544,"kind":"organization","name":"Kindred Biosciences, Inc.","symbol":"KIN"},"owners":[{"id":21194,"kind":"person","name":"Chin Richard","position":1,"cik":"0001337252","reported_name":"Chin Richard","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2020-02-13T21:28:48.000Z","date":"2020-02-11","kind":"exercise","acquired":false,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"In February 2019, the reporting person was granted 50,000 restricted stock units that vest in four equal annual installments."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"In February 2019, the reporting person was granted 50,000 restricted stock units that vest in four equal annual installments."}],"balance_after":37500,"derivative":{"underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001250853-20-000041","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1337252/000125085320000041/primary_doc.xml","form_type":"4"}},{"id":3273520,"issuer":{"id":135544,"kind":"organization","name":"Kindred Biosciences, Inc.","symbol":"KIN"},"owners":[{"id":21194,"kind":"person","name":"Chin Richard","position":1,"cik":"0001337252","reported_name":"Chin Richard","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2020-02-13T21:28:48.000Z","date":"2020-02-11","kind":"tax_withholding","acquired":false,"shares":4317,"price":9.22,"value":39802.74,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"These shares are being surrendered to satisfy a tax withholding obligation of the reporting person."}],"balance_after":1947388,"source":{"system":"sec-edgar","filing":"0001250853-20-000041","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1337252/000125085320000041/primary_doc.xml","form_type":"4"}},{"id":3273519,"issuer":{"id":135544,"kind":"organization","name":"Kindred Biosciences, Inc.","symbol":"KIN"},"owners":[{"id":21194,"kind":"person","name":"Chin Richard","position":1,"cik":"0001337252","reported_name":"Chin Richard","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2020-02-13T21:28:48.000Z","date":"2020-02-11","kind":"exercise","acquired":true,"shares":12500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":1951705,"source":{"system":"sec-edgar","filing":"0001250853-20-000041","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1337252/000125085320000041/primary_doc.xml","form_type":"4"}},{"id":3302596,"issuer":{"id":135544,"kind":"organization","name":"Kindred Biosciences, Inc.","symbol":"KIN"},"owners":[{"id":21194,"kind":"person","name":"Chin Richard","position":1,"cik":"0001337252","reported_name":"Chin Richard","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2020-01-25T00:26:36.000Z","date":"2020-01-22","kind":"exercise","acquired":false,"shares":37500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On January 22, 2018, the reporting person was granted 150,000 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On January 22, 2018, the reporting person was granted 150,000 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":75000,"derivative":{"underlying":"Common Stock","underlying_shares":37500},"source":{"system":"sec-edgar","filing":"0001250853-20-000037","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1337252/000125085320000037/primary_doc.xml","form_type":"4"}},{"id":3302595,"issuer":{"id":135544,"kind":"organization","name":"Kindred Biosciences, Inc.","symbol":"KIN"},"owners":[{"id":21194,"kind":"person","name":"Chin Richard","position":1,"cik":"0001337252","reported_name":"Chin Richard","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2020-01-25T00:26:36.000Z","date":"2020-01-23","kind":"tax_withholding","acquired":false,"shares":8645,"price":9.66,"value":83510.7,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"These shares are being surrendered to satisfy a tax withholding obligation of the reporting person."}],"balance_after":1939205,"source":{"system":"sec-edgar","filing":"0001250853-20-000037","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1337252/000125085320000037/primary_doc.xml","form_type":"4"}},{"id":3302594,"issuer":{"id":135544,"kind":"organization","name":"Kindred Biosciences, Inc.","symbol":"KIN"},"owners":[{"id":21194,"kind":"person","name":"Chin Richard","position":1,"cik":"0001337252","reported_name":"Chin Richard","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2020-01-25T00:26:36.000Z","date":"2020-01-22","kind":"tax_withholding","acquired":false,"shares":11607,"price":9.88,"value":114677.16,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"These shares are being surrendered to satisfy a tax withholding obligation of the reporting person."}],"balance_after":1947850,"source":{"system":"sec-edgar","filing":"0001250853-20-000037","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1337252/000125085320000037/primary_doc.xml","form_type":"4"}},{"id":3302593,"issuer":{"id":135544,"kind":"organization","name":"Kindred Biosciences, Inc.","symbol":"KIN"},"owners":[{"id":21194,"kind":"person","name":"Chin Richard","position":1,"cik":"0001337252","reported_name":"Chin Richard","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2020-01-25T00:26:36.000Z","date":"2020-01-22","kind":"exercise","acquired":true,"shares":37500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":1959457,"source":{"system":"sec-edgar","filing":"0001250853-20-000037","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1337252/000125085320000037/primary_doc.xml","form_type":"4"}},{"id":3305111,"issuer":{"id":135544,"kind":"organization","name":"Kindred Biosciences, Inc.","symbol":"KIN"},"owners":[{"id":21194,"kind":"person","name":"Chin Richard","position":1,"cik":"0001337252","reported_name":"Chin Richard","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2020-01-23T01:46:11.000Z","date":"2020-01-17","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units shall vest in four equal annual installments following the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units shall vest in four equal annual installments following the date of grant."}],"balance_after":150000,"derivative":{"underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001250853-20-000030","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1337252/000125085320000030/primary_doc.xml","form_type":"4"}},{"id":3305110,"issuer":{"id":135544,"kind":"organization","name":"Kindred Biosciences, Inc.","symbol":"KIN"},"owners":[{"id":21194,"kind":"person","name":"Chin Richard","position":1,"cik":"0001337252","reported_name":"Chin Richard","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2020-01-23T01:46:11.000Z","date":"2020-01-17","kind":"grant","acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest as to 25% after one year following the date of grant, and the remainder will vest in 36 equal monthly installments over the following three years."}],"balance_after":300000,"derivative":{"exercise_price":9.84,"expiration_date":"2030-01-16","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001250853-20-000030","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1337252/000125085320000030/primary_doc.xml","form_type":"4"}},{"id":3673755,"issuer":{"id":135544,"kind":"organization","name":"Kindred Biosciences, Inc.","symbol":"KIN"},"owners":[{"id":21194,"kind":"person","name":"Chin Richard","position":1,"cik":"0001337252","reported_name":"Chin Richard","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2019-02-06T00:25:42.000Z","date":"2019-02-01","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units shall vest in four equal annual installments following the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units shall vest in four equal annual installments following the date of grant."}],"balance_after":50000,"derivative":{"underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001250853-19-000046","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1337252/000125085319000046/primary_doc.xml","form_type":"4"}},{"id":3673754,"issuer":{"id":135544,"kind":"organization","name":"Kindred Biosciences, Inc.","symbol":"KIN"},"owners":[{"id":21194,"kind":"person","name":"Chin Richard","position":1,"cik":"0001337252","reported_name":"Chin Richard","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2019-02-06T00:25:42.000Z","date":"2019-02-01","kind":"grant","acquired":true,"shares":400000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest as to 25% after one year following the date of grant, and the remainder will vest in 36 equal monthly installments over the following three years."}],"balance_after":400000,"derivative":{"exercise_price":9.91,"expiration_date":"2029-01-31","underlying":"Common Stock","underlying_shares":400000},"source":{"system":"sec-edgar","filing":"0001250853-19-000046","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1337252/000125085319000046/primary_doc.xml","form_type":"4"}},{"id":3687854,"issuer":{"id":135544,"kind":"organization","name":"Kindred Biosciences, Inc.","symbol":"KIN"},"owners":[{"id":21194,"kind":"person","name":"Chin Richard","position":1,"cik":"0001337252","reported_name":"Chin Richard","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2019-01-25T02:56:44.000Z","date":"2019-01-22","kind":"exercise","acquired":false,"shares":37500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On January 22, 2018, the reporting person was granted 150,000 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On January 22, 2018, the reporting person was granted 150,000 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":112500,"derivative":{"underlying":"Common Stock","underlying_shares":37500},"source":{"system":"sec-edgar","filing":"0001250853-19-000036","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1337252/000125085319000036/primary_doc.xml","form_type":"4"}},{"id":3687853,"issuer":{"id":135544,"kind":"organization","name":"Kindred Biosciences, Inc.","symbol":"KIN"},"owners":[{"id":21194,"kind":"person","name":"Chin Richard","position":1,"cik":"0001337252","reported_name":"Chin Richard","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2019-01-25T02:56:44.000Z","date":"2019-01-23","kind":"tax_withholding","acquired":false,"shares":8646,"price":9.945,"value":85984.47,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"These shares are being surrendered to satisfy a tax withholding obligation of the reporting person."}],"balance_after":1921957,"source":{"system":"sec-edgar","filing":"0001250853-19-000036","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1337252/000125085319000036/primary_doc.xml","form_type":"4"}},{"id":3687852,"issuer":{"id":135544,"kind":"organization","name":"Kindred Biosciences, Inc.","symbol":"KIN"},"owners":[{"id":21194,"kind":"person","name":"Chin Richard","position":1,"cik":"0001337252","reported_name":"Chin Richard","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2019-01-25T02:56:44.000Z","date":"2019-01-22","kind":"tax_withholding","acquired":false,"shares":12968,"price":10.12,"value":131236.16,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"These shares are being surrendered to satisfy a tax withholding obligation of the reporting person."}],"balance_after":1930603,"source":{"system":"sec-edgar","filing":"0001250853-19-000036","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1337252/000125085319000036/primary_doc.xml","form_type":"4"}},{"id":3687851,"issuer":{"id":135544,"kind":"organization","name":"Kindred Biosciences, Inc.","symbol":"KIN"},"owners":[{"id":21194,"kind":"person","name":"Chin Richard","position":1,"cik":"0001337252","reported_name":"Chin Richard","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2019-01-25T02:56:44.000Z","date":"2019-01-22","kind":"exercise","acquired":true,"shares":37500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":1943571,"source":{"system":"sec-edgar","filing":"0001250853-19-000036","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1337252/000125085319000036/primary_doc.xml","form_type":"4"}},{"id":3703351,"issuer":{"id":135544,"kind":"organization","name":"Kindred Biosciences, Inc.","symbol":"KIN"},"owners":[{"id":21194,"kind":"person","name":"Chin Richard","position":1,"cik":"0001337252","reported_name":"Chin Richard","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2019-01-05T01:41:46.000Z","date":"2019-01-02","kind":"sale","acquired":false,"shares":40000,"price":10.5679,"value":422716.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on December 11, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.41 to $10.91, inclusive."}],"balance_after":1906071,"source":{"system":"sec-edgar","filing":"0001250853-19-000020","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1337252/000125085319000020/primary_doc.xml","form_type":"4"}},{"id":3743320,"issuer":{"id":135544,"kind":"organization","name":"Kindred Biosciences, Inc.","symbol":"KIN"},"owners":[{"id":21194,"kind":"person","name":"Chin Richard","position":1,"cik":"0001337252","reported_name":"Chin Richard","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2018-12-05T00:00:26.000Z","date":"2018-12-03","kind":"sale","acquired":false,"shares":40000,"price":13.28,"value":531200.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on December 11, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.90 to $13.68, inclusive."}],"balance_after":1946071,"source":{"system":"sec-edgar","filing":"0001250853-18-000145","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1337252/000125085318000145/primary_doc.xml","form_type":"4"}},{"id":3775544,"issuer":{"id":135544,"kind":"organization","name":"Kindred Biosciences, Inc.","symbol":"KIN"},"owners":[{"id":21194,"kind":"person","name":"Chin Richard","position":1,"cik":"0001337252","reported_name":"Chin Richard","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO"}}],"security":"COMMON STOCK","published_at":"2018-11-02T23:47:31.000Z","date":"2018-11-01","kind":"sale","acquired":false,"shares":40000,"price":14.68,"value":587200.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 11, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $14.09 to $14.90, inclusive."}],"balance_after":1986071,"source":{"system":"sec-edgar","filing":"0001250853-18-000137","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1337252/000125085318000137/primary_doc.xml","form_type":"4"}},{"id":3798112,"issuer":{"id":135544,"kind":"organization","name":"Kindred Biosciences, Inc.","symbol":"KIN"},"owners":[{"id":21194,"kind":"person","name":"Chin Richard","position":1,"cik":"0001337252","reported_name":"Chin Richard","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2018-10-03T21:15:03.000Z","date":"2018-10-01","kind":"sale","acquired":false,"shares":40000,"price":13.28,"value":531200.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan  adopted by the reporting person on December 11, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $12.94 to $13.86, inclusive."}],"balance_after":2026071,"source":{"system":"sec-edgar","filing":"0001250853-18-000126","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1337252/000125085318000126/primary_doc.xml","form_type":"4"}},{"id":3823116,"issuer":{"id":135544,"kind":"organization","name":"Kindred Biosciences, Inc.","symbol":"KIN"},"owners":[{"id":21194,"kind":"person","name":"Chin Richard","position":1,"cik":"0001337252","reported_name":"Chin Richard","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"COMMON STOCK","published_at":"2018-09-07T00:07:12.000Z","date":"2018-09-05","kind":"sale","acquired":false,"shares":7600,"price":14.69,"value":111644.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 11, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $14.55 to $14.80, inclusive."}],"balance_after":2066071,"source":{"system":"sec-edgar","filing":"0001250853-18-000121","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1337252/000125085318000121/primary_doc.xml","form_type":"4"}},{"id":3823115,"issuer":{"id":135544,"kind":"organization","name":"Kindred Biosciences, Inc.","symbol":"KIN"},"owners":[{"id":21194,"kind":"person","name":"Chin Richard","position":1,"cik":"0001337252","reported_name":"Chin Richard","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"COMMON STOCK","published_at":"2018-09-07T00:07:12.000Z","date":"2018-09-04","kind":"sale","acquired":false,"shares":32400,"price":14.81,"value":479844.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 11, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $14.75 to $14.95, inclusive."}],"balance_after":2073671,"source":{"system":"sec-edgar","filing":"0001250853-18-000121","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1337252/000125085318000121/primary_doc.xml","form_type":"4"}},{"id":3852879,"issuer":{"id":135544,"kind":"organization","name":"Kindred Biosciences, Inc.","symbol":"KIN"},"owners":[{"id":21194,"kind":"person","name":"Chin Richard","position":1,"cik":"0001337252","reported_name":"Chin Richard","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2018-08-04T01:06:28.000Z","date":"2018-08-01","kind":"sale","acquired":false,"shares":40000,"price":13.51,"value":540400.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 11, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $13.40 to $13.80, inclusive."}],"balance_after":2106071,"source":{"system":"sec-edgar","filing":"0001250853-18-000111","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1337252/000125085318000111/primary_doc.xml","form_type":"4"}},{"id":3874276,"issuer":{"id":135544,"kind":"organization","name":"Kindred Biosciences, Inc.","symbol":"KIN"},"owners":[{"id":21194,"kind":"person","name":"Chin Richard","position":1,"cik":"0001337252","reported_name":"Chin Richard","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2018-07-03T21:57:07.000Z","date":"2018-07-02","kind":"sale","acquired":false,"shares":40000,"price":10.28,"value":411200.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 11, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.05 to $10.50, inclusive."}],"balance_after":2146071,"source":{"system":"sec-edgar","filing":"0001250853-18-000095","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1337252/000125085318000095/primary_doc.xml","form_type":"4"}},{"id":3910410,"issuer":{"id":135544,"kind":"organization","name":"Kindred Biosciences, Inc.","symbol":"KIN"},"owners":[{"id":21194,"kind":"person","name":"Chin Richard","position":1,"cik":"0001337252","reported_name":"Chin Richard","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"COMMON STOCK","published_at":"2018-06-01T23:07:18.000Z","date":"2018-06-01","kind":"sale","acquired":false,"shares":40000,"price":10.13,"value":405200.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 11, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $10.00 to $10.35, inclusive."}],"balance_after":2186071,"source":{"system":"sec-edgar","filing":"0001250853-18-000079","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1337252/000125085318000079/primary_doc.xml","form_type":"4"}},{"id":3910409,"issuer":{"id":135544,"kind":"organization","name":"Kindred Biosciences, Inc.","symbol":"KIN"},"owners":[{"id":21194,"kind":"person","name":"Chin Richard","position":1,"cik":"0001337252","reported_name":"Chin Richard","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"COMMON STOCK","published_at":"2018-06-01T23:07:18.000Z","date":"2018-05-30","kind":"sale","acquired":false,"shares":12610,"price":10,"value":126100.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 11, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $10.00 to $10.05, inclusive."}],"balance_after":2226071,"source":{"system":"sec-edgar","filing":"0001250853-18-000079","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1337252/000125085318000079/primary_doc.xml","form_type":"4"}},{"id":3915138,"issuer":{"id":135544,"kind":"organization","name":"Kindred Biosciences, Inc.","symbol":"KIN"},"owners":[{"id":21194,"kind":"person","name":"Chin Richard","position":1,"cik":"0001337252","reported_name":"Chin Richard","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"COMMON STOCK","published_at":"2018-05-29T23:48:16.000Z","date":"2018-05-25","kind":"sale","acquired":false,"shares":3000,"price":10,"value":30000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 11, 2017."}],"balance_after":2238681,"source":{"system":"sec-edgar","filing":"0001250853-18-000078","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1337252/000125085318000078/primary_doc.xml","form_type":"4"}},{"id":3915137,"issuer":{"id":135544,"kind":"organization","name":"Kindred Biosciences, Inc.","symbol":"KIN"},"owners":[{"id":21194,"kind":"person","name":"Chin Richard","position":1,"cik":"0001337252","reported_name":"Chin Richard","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"COMMON STOCK","published_at":"2018-05-29T23:48:16.000Z","date":"2018-05-24","kind":"sale","acquired":false,"shares":60,"price":10,"value":600.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 11, 2017."}],"balance_after":2241681,"source":{"system":"sec-edgar","filing":"0001250853-18-000078","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1337252/000125085318000078/primary_doc.xml","form_type":"4"}},{"id":3925458,"issuer":{"id":135544,"kind":"organization","name":"Kindred Biosciences, Inc.","symbol":"KIN"},"owners":[{"id":21194,"kind":"person","name":"Chin Richard","position":1,"cik":"0001337252","reported_name":"Chin Richard","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"COMMON STOCK","published_at":"2018-05-18T22:35:52.000Z","date":"2018-05-18","kind":"sale","acquired":false,"shares":2400,"price":10,"value":24000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 11, 2017"}],"balance_after":2241741,"source":{"system":"sec-edgar","filing":"0001250853-18-000077","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1337252/000125085318000077/primary_doc.xml","form_type":"4"}},{"id":3940653,"issuer":{"id":135544,"kind":"organization","name":"Kindred Biosciences, Inc.","symbol":"KIN"},"owners":[{"id":21194,"kind":"person","name":"Chin Richard","position":1,"cik":"0001337252","reported_name":"Chin Richard","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"COMMON STOCK","published_at":"2018-05-09T23:28:15.000Z","date":"2018-05-09","kind":"sale","acquired":false,"shares":200,"price":10,"value":2000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 11, 2017."}],"balance_after":2244141,"source":{"system":"sec-edgar","filing":"0001250853-18-000074","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1337252/000125085318000074/primary_doc.xml","form_type":"4"}},{"id":3940652,"issuer":{"id":135544,"kind":"organization","name":"Kindred Biosciences, Inc.","symbol":"KIN"},"owners":[{"id":21194,"kind":"person","name":"Chin Richard","position":1,"cik":"0001337252","reported_name":"Chin Richard","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"COMMON STOCK","published_at":"2018-05-09T23:28:15.000Z","date":"2018-05-07","kind":"sale","acquired":false,"shares":1730,"price":10.01,"value":17317.3,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 11, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $10.00 to $10.15, inclusive."}],"balance_after":2244341,"source":{"system":"sec-edgar","filing":"0001250853-18-000074","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1337252/000125085318000074/primary_doc.xml","form_type":"4"}},{"id":3949543,"issuer":{"id":135544,"kind":"organization","name":"Kindred Biosciences, Inc.","symbol":"KIN"},"owners":[{"id":21194,"kind":"person","name":"Chin Richard","position":1,"cik":"0001337252","reported_name":"Chin Richard","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2018-05-03T00:34:26.000Z","date":"2018-05-01","kind":"sale","acquired":false,"shares":20000,"price":9.05,"value":181000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 11, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.95 to $9.25, inclusive."}],"balance_after":2246071,"source":{"system":"sec-edgar","filing":"0001250853-18-000070","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1337252/000125085318000070/primary_doc.xml","form_type":"4"}},{"id":3969367,"issuer":{"id":135544,"kind":"organization","name":"Kindred Biosciences, Inc.","symbol":"KIN"},"owners":[{"id":21194,"kind":"person","name":"Chin Richard","position":1,"cik":"0001337252","reported_name":"Chin Richard","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2018-04-04T23:08:17.000Z","date":"2018-04-02","kind":"sale","acquired":false,"shares":20000,"price":8.39,"value":167800.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 11, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.20 to $8.65, inclusive."}],"balance_after":2266071,"source":{"system":"sec-edgar","filing":"0001250853-18-000055","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1337252/000125085318000055/primary_doc.xml","form_type":"4"}},{"id":4090875,"issuer":{"id":135544,"kind":"organization","name":"Kindred Biosciences, Inc.","symbol":"KIN"},"owners":[{"id":21194,"kind":"person","name":"Chin Richard","position":1,"cik":"0001337252","reported_name":"Chin Richard","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Units","published_at":"2018-01-25T01:24:12.000Z","date":"2018-01-22","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option will vest as to 25% annually following the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The option will vest as to 25% annually following the date of grant."}],"balance_after":150000,"derivative":{"underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001250853-18-000028","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1337252/000125085318000028/primary_doc.xml","form_type":"4"}},{"id":4090874,"issuer":{"id":135544,"kind":"organization","name":"Kindred Biosciences, Inc.","symbol":"KIN"},"owners":[{"id":21194,"kind":"person","name":"Chin Richard","position":1,"cik":"0001337252","reported_name":"Chin Richard","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2018-01-25T01:24:12.000Z","date":"2018-01-22","kind":"grant","acquired":true,"shares":175000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest as to 25% after one year following the date of grant, and the remainder will vest in equal monthly installments over the following three years."}],"balance_after":175000,"derivative":{"exercise_price":8.75,"expiration_date":"2028-01-22","underlying":"Commmon Stock","underlying_shares":175000},"source":{"system":"sec-edgar","filing":"0001250853-18-000028","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1337252/000125085318000028/primary_doc.xml","form_type":"4"}},{"id":4090873,"issuer":{"id":135544,"kind":"organization","name":"Kindred Biosciences, Inc.","symbol":"KIN"},"owners":[{"id":21194,"kind":"person","name":"Chin Richard","position":1,"cik":"0001337252","reported_name":"Chin Richard","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2018-01-25T01:24:12.000Z","date":"2018-01-23","kind":"tax_withholding","acquired":false,"shares":11475,"price":9.15,"value":104996.25,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"These shares are being surrendered to satisfy a tax withholding obligation of the reporting person."}],"balance_after":2286071,"source":{"system":"sec-edgar","filing":"0001250853-18-000028","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1337252/000125085318000028/primary_doc.xml","form_type":"4"}},{"id":4188789,"issuer":{"id":4313,"kind":"organization","name":"SELLAS Life Sciences Group, Inc."},"owners":[{"id":21194,"kind":"person","name":"Chin Richard","position":1,"cik":"0001337252","reported_name":"Chin Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-10-10T21:45:21.000Z","date":"2017-10-10","kind":"grant","acquired":true,"shares":12708,"price":0.38,"value":4829.04,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Effective January 1, 2017, 33% of the cash retainer payments to our Board will be paid in unrestricted shares of the Company's common stock, delivered from the 2016 Incentive Plan and priced on the first trading day of the quarter."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the closing stock price of the Company's stock on the first trading day of the quarter."}],"balance_after":31339,"source":{"system":"sec-edgar","filing":"0001394548-17-000027","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1337252/000139454817000027/primary_doc.xml","form_type":"4"}},{"id":4261551,"issuer":{"id":135544,"kind":"organization","name":"Kindred Biosciences, Inc.","symbol":"KIN"},"owners":[{"id":21194,"kind":"person","name":"Chin Richard","position":1,"cik":"0001337252","reported_name":"Chin Richard","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2017-07-06T21:50:44.000Z","date":"2017-07-03","kind":"sale","acquired":false,"shares":13000,"price":8.26,"value":107380.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $8.15 to $8.65, inclusive.  The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 23, 2017."}],"balance_after":2297546,"source":{"system":"sec-edgar","filing":"0001250853-17-000060","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1337252/000125085317000060/primary_doc.xml","form_type":"4"}},{"id":4261550,"issuer":{"id":4313,"kind":"organization","name":"SELLAS Life Sciences Group, Inc."},"owners":[{"id":21194,"kind":"person","name":"Chin Richard","position":1,"cik":"0001337252","reported_name":"Chin Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-07-06T21:30:06.000Z","date":"2017-06-08","kind":"grant","acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Granted pursuant to the Issuer's 2016 Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This stock option will vest and become exercisable in equal quarterly installments over one year beginning three months from June 8, 2017, such that the option will be fully exercisable as of June 8, 2018."}],"balance_after":5000,"derivative":{"exercise_price":0.55,"expiration_date":"2027-06-08","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001394548-17-000022","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1337252/000139454817000022/primary_doc.xml","form_type":"4"}},{"id":4261549,"issuer":{"id":4313,"kind":"organization","name":"SELLAS Life Sciences Group, Inc."},"owners":[{"id":21194,"kind":"person","name":"Chin Richard","position":1,"cik":"0001337252","reported_name":"Chin Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-07-06T21:30:06.000Z","date":"2017-07-06","kind":"grant","acquired":true,"shares":8104,"price":0.59,"value":4781.36,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Effective January 1, 2017, 33% of the cash retainer payments to our Board will be pain in unrestricted shares of the Company's common stock delivered from the 2016 Incentive Plan and priced on the first trading day of the quarter."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the closing stock price of the Company's stock on the first trading day of the quarter."}],"balance_after":18631,"source":{"system":"sec-edgar","filing":"0001394548-17-000022","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1337252/000139454817000022/primary_doc.xml","form_type":"4"}},{"id":4272443,"issuer":{"id":135544,"kind":"organization","name":"Kindred Biosciences, Inc.","symbol":"KIN"},"owners":[{"id":21194,"kind":"person","name":"Chin Richard","position":1,"cik":"0001337252","reported_name":"Chin Richard","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2017-06-26T11:42:38.000Z","date":"2017-06-22","kind":"sale","acquired":false,"shares":13000,"price":7.75,"value":100750.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 23, 2017."}],"balance_after":2310546,"source":{"system":"sec-edgar","filing":"0001250853-17-000058","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1337252/000125085317000058/primary_doc.xml","form_type":"4"}},{"id":4353296,"issuer":{"id":4313,"kind":"organization","name":"SELLAS Life Sciences Group, Inc."},"owners":[{"id":21194,"kind":"person","name":"Chin Richard","position":1,"cik":"0001337252","reported_name":"Chin Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-04-12T20:56:50.000Z","date":"2017-04-10","kind":"grant","acquired":true,"shares":8107,"price":0.59,"value":4783.13,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Effective January 1, 2017, 33% of the cash retainer payment to our Board will be paid in unrestricted shares of the Company's common stock, delivered from the 2016 Incentive Plan and priced on the first trading day of the quarter."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the closing stock price of the Company's stock on the first trading day of the quarter."}],"balance_after":10527,"source":{"system":"sec-edgar","filing":"0001394548-17-000013","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1337252/000139454817000013/primary_doc.xml","form_type":"4"}},{"id":4481791,"issuer":{"id":135544,"kind":"organization","name":"Kindred Biosciences, Inc.","symbol":"KIN"},"owners":[{"id":21194,"kind":"person","name":"Chin Richard","position":1,"cik":"0001337252","reported_name":"Chin Richard","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option (right to buy)","published_at":"2017-01-26T01:23:35.000Z","date":"2017-01-23","kind":"grant","acquired":true,"shares":175000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option will vest as to 25% after one year following the date of grant, and the remainder will vest in equal monthly installments over the following three years."}],"balance_after":175000,"derivative":{"exercise_price":6.4,"expiration_date":"2027-01-23","underlying":"Common Stock","underlying_shares":175000},"source":{"system":"sec-edgar","filing":"0001250853-17-000022","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1337252/000125085317000022/primary_doc.xml","form_type":"4"}},{"id":4481790,"issuer":{"id":135544,"kind":"organization","name":"Kindred Biosciences, Inc.","symbol":"KIN"},"owners":[{"id":21194,"kind":"person","name":"Chin Richard","position":1,"cik":"0001337252","reported_name":"Chin Richard","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2017-01-26T01:23:35.000Z","date":"2017-01-23","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":2323546,"source":{"system":"sec-edgar","filing":"0001250853-17-000022","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1337252/000125085317000022/primary_doc.xml","form_type":"4"}},{"id":4481789,"issuer":{"id":135544,"kind":"organization","name":"Kindred Biosciences, Inc.","symbol":"KIN"},"owners":[{"id":21194,"kind":"person","name":"Chin Richard","position":1,"cik":"0001337252","reported_name":"Chin Richard","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2017-01-26T01:23:35.000Z","date":"2016-05-17","kind":"gift","acquired":false,"shares":400000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction involved a gift of securities by the reporting person to a family trust."}],"balance_after":2223546,"source":{"system":"sec-edgar","filing":"0001250853-17-000022","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1337252/000125085317000022/primary_doc.xml","form_type":"4"}},{"id":4482814,"issuer":{"id":4313,"kind":"organization","name":"SELLAS Life Sciences Group, Inc."},"owners":[{"id":21194,"kind":"person","name":"Chin Richard","position":1,"cik":"0001337252","reported_name":"Chin Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-01-24T23:00:16.000Z","date":"2017-01-20","kind":"grant","acquired":true,"shares":2420,"price":1.98,"value":4791.6,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Effective January 1, 2017, 33% of the cash retainer payments to our Board will be paid in unrestricted shares of the Company's common stock, delivered from the 2016 Incentive Plan and priced on the first trading day of the quarter."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the closing stock price of the Company's stock on the first trading day of the quarter."}],"balance_after":2420,"source":{"system":"sec-edgar","filing":"0001394548-17-000005","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1337252/000139454817000005/primary_doc.xml","form_type":"4"}}]}